We all know that Covid-19 has taken a toll on humanity, spreading across almost all countries, infecting more than 225,000 people globally, and taking lives of 9,000+ people.
Complimentary Coronavirus Research Assistance Program
Our Business associate ‘Sagacious IP’ is Offering 1,000 Hours of Complimentary Research Assistance to the Global Researchers working on prevention / cure for COVID-19. Aagami has partnered to contribute in getting this valuable assistance available to the Research Fraternity.
Share this page and help us reach the right COVID-19 researchers who can benefit from this initiative.
About Sagacious and the Coronavirus Research Assistance Program
- We believe that a sure shot way out for now would be to find quick diagnosis and a confirmed cure / prevention.
- Keeping this in mind and knowing the expertise of Sagacious IP, (one of the largest IP, non-IP literature information providers globally), are donating 1000 hours of professional support.
- Sagacious has one of the widest access to global patent/non-patent literature in multiple languages and has diverse multi-lingual team to analyse and translate all such literature.
- Sagacious have in the past successfully supported development of cure for many rare diseases by working closely with researchers.
- As a partner to Sagacious, we too are accordingly - committed to help researchers, get timely & exhaustive information about previous research on Corona/similar viruses so they can accelerate their efforts to find a cure/prevention.
- The support may involve analysing all literature till date and putting the findings at where all researchers can access the detailed analysis; pick and choose what information they need. Alternatively, Sagacious can offer custom information support to specific research groups as they reach out to us.
- More details about the Coronavirus Research Assistance Program and an initial report about current treatment, etc. is available here: https://www.sagaciousresearch.com/coronavirus-research-assistance/
About the complimentary report:
Name: CORONAVIRUS PATENT & NON-PATENT LITERATURE OVERVIEW
Format: PDF only.
Description: The report provides a quick overview of the current therapies provided to the patients, therapies and diagnostic kits in pipeline, current collaborations amongst the firms and details of our assistance program as well.